Fig. 5: Proteo-genomics analysis of cancer driver events in breast cancer.
From: Connecting omics signatures and revealing biological mechanisms with iLINCS

a Most differentially expressed proteins in the proteomics signatures constructed by comparing RPPA profiles of Her2E and Luminal-A BRC samples. b Gene expression profile of the genes corresponding to proteins in (a) based on RNA-seq data. c The transcriptional signature consisting of all highly differentially expressed genes (unadjusted, two-tailed P value<10−10). d Enrichment analysis of genes upregulated in Luminal A, and upregulated in Her2E tumors via Enrich (unadjusted Fisher Exact Test P values).